StockTipsArenaBeta

BUY IPCA Laboratories Limited — Aditya Agarwal, Coheron Brokers

BUYIPCA Laboratories Limited
IPCA Laboratories share price target & all analyst calls

byAditya Agarwal, Coheron BrokersHorizon: NA (inferred Swing (≤2wk))23 Jun 2026via Business Today

Entry₹1,626Inferred
Target₹1,700
Total upside +4.55% (call closed)
Stop lossNot given
Exit₹1,70030 Jun 2026, 12:35 pm
Target hit+4.55%0.00%upside left
Follow Aditya Agarwal for new calls(30% target hit, 23 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:23 pm IST
3 supporting0 opposing
Supports the BUY call (3)

IPCA Laboratories Limited's Board approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. with Ipca Laboratories Ltd. The merger aims for operational synergies, cost optimization,

NSE · Outcome of Board Meeting·26 Jun · 3d ago

(opens in new tab)

IPCA Laboratories has entered a licensing agreement to access a proprietary biologics delivery platform for developing oncology and inflammatory disease treatments.

NSE · Press Release·12 Jun · 2w ago

(opens in new tab)

Ipca Laboratories has entered into a global licensing agreement with Bhami's Research Laboratory (BRL) for BRL's proprietary high-concentration subcutaneous biologics delivery platform. This collabora

BSE · Company Update·12 Jun · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IPCA Laboratories

All analyst calls on IPCA Laboratories

More from Aditya Agarwal, Coheron Brokers

Every call and its outcome